$CDLX Cashflow Statement | Understand Stock

$CDLX

$1.65 -$0.15 (8.33%) Close

$CDLX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net Loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Credit loss expense
Depreciation and amortization
Amortization of financing costs charged to interest expense
Amortization of right-of-use asset
Impairment of goodwill and intangible assets
Gain (Loss) on Disposition of Business
Gain on debt extinguishment
Stock-based compensation expense
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease)
Other non-cash expense (income), net
Deferred implementation costs
Income tax benefit
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital
Accounts receivable and contracts assets, net
Prepaid expenses and other assets
Recovery of deferred implementation costs
Accounts payable
Other accrued expenses
Partner Share liability
Customer Incentive liability
Net cash provided by (used in) operating activities
Investing activities
Acquisition of property and equipment
Acquisition of patents
Capitalized software development costs
Business acquisitions, net of cash acquired
Proceeds from Divestiture of Businesses, Net of Cash Divested
Net cash used in investing activities
Financing activities
Proceeds from issuance of debt
Principal payments of debt
Purchase of capped calls related to convertible senior notes
Proceeds from termination of capped calls related to convertible notes
Proceeds from issuance of common stock
Settlement of contingent consideration
Repurchase of common stock
Equity issuance costs
Debt issuance costs
Net cash (used in) provided by financing activities

Effect of exchange rates on cash, cash equivalents and restricted cash
Net decrease in cash, cash equivalents and restricted cash
Cash, cash equivalents, and restricted cash — Beginning of period
Cash, cash equivalents, and restricted cash — End of period
Supplemental schedule of non-cash investing and financing activities:
Cash paid for interest
Amounts accrued for property and equipment
Amounts accrued for capitalized software development costs
Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below)
Supplemental Cash Flow Information
Cash and cash equivalents
Restricted cash

Comments